Local Delivery of Glabridin by Biomolecular Microneedle to Accelerate Infected Wound Healing

Applying antibacterial polymers and pro-regenerative small molecules are two individual strategies for accelerating wound healing. However, integrating those two unique approaches into one therapeutic platform that meets clinical requirements is still a challenge. Herein, a series of antibacterial gelatin methacrylate (GelMA)/epsilon-polylysine (epsilon-PL) composite hydrogels (termed as GP-n HGs, n = 0, 10, 20, and 30, respectively) are innovatively fabricated by ultraviolet light (UV) crosslinking. The GP-n HGs are proved to be broad-spectrum antibacterial and biocompatible. Among those GP-n HGs, the GP-20 HG is selectively processed into microneedle following a mold-casting method. Then, the glabridin is loaded into those needles to produce composite microneedle termed GP-20@Gla MN. An S. aureus-infected full-thickness defect model in rats is created to evaluate the wound-healing effect of GP-20@Gla MN. Furthermore, an RNA sequencing assay is performed to explore the possible molecular mechanisms of glabridin in promoting tissue regeneration, and many positive routes are summarized. This work is of significant novelty in fulfilling complex clinical needs by simultaneously optimizing the advanced microneedles' chemical compositions and physical structures. This work will provide a promising therapeutic platform for treating infected and chronic wounds. The current research involves the development of an advanced microneedle system which represents the first report of a complete approach that integrates antibacterial polymers and pro-regenerative small molecules into a single therapeutic platform. This platform addresses the multiple clinical requirements associated with the treatment of acute and chronic wounds, hence offering an exciting potential for the treatment of wounds.image

Automated summary

This study successfully integrates antibacterial polymers and pro-regenerative small molecules through the fabrication of antibacterial composite hydrogels and the construction of composite microneedles, providing a promising therapeutic platform for treating infected and chronic wounds.